Danaher Corporation

NYSE:DHR

Medical - Diagnostics & Research

Healthcare
$228.41 -0.21%

-$0.38 today

Market cap
$160.69B
Beta
0.83
P/E (TTM)
34.0
EPS (TTM)
$5.21
Dividend yield
0.77%
52W Low $160.93High $242.80

Volume 2.92M

Average 4.52M

DHR EBITDA Margin

EBITDA as a percentage of revenue.

Danaher CorporationNYSE: DHR

EBITDA Margin · Q3 FY2026 · quarter ended Sep 2026

EBITDA Margin narrows to 19.3%

EBITDA Margin was 19.3% in Q3 FY2026, down 9.8 pp from a year earlier. On a trailing-twelve-month basis it was 27.7%, down 0.6 pp year over year. Over 3 fiscal years it narrowed by 7.3 pp.

Context

  • EBITDA Margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 17 analysts of 35.4% for the fiscal year ending Dec 2026, up from 28.3% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
19.3%-10.1 pp QoQ
Last fiscal yearDec 2025
28.3%-2.2 pp YoY
LTMSep 2026
27.7%-0.6 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-9.8 pp+4.9 pp+14.7 pp
1 year-2.2 pp+7.2 pp+9.4 pp
3 years-7.3 pp+6.0 pp+13.3 pp
5 years+6.9 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
28.3%
Year-over-year change
-2.2pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How DHR compares with its peers on the latest reported figures

  • DHR's LTM Sep 2026 EBITDA Margin of 27.7% is the 4th highest of the 9 companies compared; the peer median is 27.0%.
  • Its year-over-year change of -0.6 pp is the 3rd highest of 9, against a peer median of -2.6 pp.
  • Over three fiscal years its change of -7.3 pp compares with a peer median of -1.7 pp.
DHR Competitors Peer median
EBITDA Margin for DHR and competitors
Company Period LTM level YoY 3-year change
QGENQiagen N.V.LTM Jun 202633.5% -1.6 pp-2.1 pp
MTDMettler-Toledo International Inc.LTM Jun 202631.6% +0.0 pp-0.7 pp
ILMNIllumina, Inc.LTM Jun 202630.3% -11.3 pp+119.0 pp
DHRDanaher CorporationLTM Sep 202627.7% -0.6 pp-7.3 pp
AAgilent Technologies, Inc.LTM Jul 202627.6% +1.1 pp-1.4 pp
RVTYRevvity, Inc.LTM Jul 202626.3% -3.0 pp-8.9 pp
TMOThermo Fisher Scientific Inc.LTM Sep 202623.7% -2.2 pp-0.9 pp
WATWaters CorporationLTM Jul 202620.5% -14.2 pp-2.3 pp
BRKRBruker CorporationLTM Jun 20267.1% -4.6 pp-11.7 pp
Peer median (excluding DHR) 27.0%-2.6 pp-1.7 pp

Competitors are the stored peer set for DHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue29.45B26.64B23.89B23.88B24.57B
Cost of Revenue11.5B10.46B9.86B9.67B9.6B
Gross Profit17.95B16.19B14.03B14.21B14.97B
Gross Margin61.0%60.8%58.7%59.5%60.9%
Research & Development1.74B1.53B1.5B1.58B1.6B
Selling, General & Admin8.16B7.12B7.25B7.44B8.24B
Operating Expenses9.9B8.65B8.76B9.02B9.83B
Depreciation & Amortization2.17B2.13B2.17B2.35B2.45B
EBITDA10.01B9.49B7.5B7.28B6.95B
EBITDA Margin34.0%35.6%31.4%30.5%28.3%
Operating Income8.05B7.54B5.28B5.18B5.14B
Operating Margin27.3%28.3%22.1%21.7%20.9%
Interest Income11M41M303M117M30M
Interest Expense241M207M289M278M265M
Other Income / Expenses(452M)(390M)(235M)(538M)(904M)
Income Before Tax7.6B7.15B5.04B4.65B4.23B
Pre-Tax Margin25.8%26.8%21.1%19.5%17.2%
Income Tax Expense1.25B818M823M747M619M
Net Income6.43B7.21B4.76B3.9B3.61B
Net Margin21.8%27.1%19.9%16.3%14.7%
EPS (Basic)8.779.806.445.335.07
EPS (Diluted)8.619.646.385.295.04
Weighted Avg Shares714.6M725.1M736.5M731M707.3M
Weighted Avg Shares (Diluted)736.8M737.1M743.1M737.2M711M

Danaher Corporation

NYSE:DHR

Intrinsic Alpha fair value

Locked

Current Price

$228.41

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.